Review
Published on 07 May 2020
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
in Cardio-Oncology

- 8,137 views
- 34 citations
Review
Published on 07 May 2020
in Cardio-Oncology
Review
Published on 28 Apr 2020
in Cardio-Oncology
Review
Published on 08 Apr 2020
in Cardio-Oncology
Mini Review
Published on 20 Mar 2020
in Cardio-Oncology
Review
Published on 18 Mar 2020
in Cardio-Oncology
Mini Review
Published on 12 Mar 2020
in Cardio-Oncology
Review
Published on 10 Mar 2020
in Cardio-Oncology
Review
Published on 10 Mar 2020
in Cardio-Oncology
Brief Research Report
Published on 05 Mar 2020
in Cardio-Oncology
Mini Review
Published on 21 Feb 2020
in Cardio-Oncology
Mini Review
Published on 21 Feb 2020
in Cardio-Oncology
Original Research
Published on 14 Feb 2020
in Cardio-Oncology
Review
Published on 24 Jan 2020
in Cardio-Oncology
Opinion
Published on 10 Jan 2020
in Cardio-Oncology
Case Report
Published on 23 Aug 2019
in Cardio-Oncology
Editorial
Published on 10 Apr 2019
in Cardio-Oncology